Mårten Segelmark
101 – 110 of 188
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Diagnosis and classification of Goodpasture's disease (anti-GBM).
(
- Contribution to journal › Scientific review
-
Mark
Primary systemic vasculitis with severe α1-antitrypsin deficiency revisited.
(
- Contribution to journal › Article
-
Mark
In Reply to 'IgG4-Restricted Anti-Glomerular Basement Membrane Autoantibodies Targeting Quaternary Epitopes of Native α345(IV) Collagen'
(
- Contribution to journal › Letter
-
Mark
Glomerulonephritides.
2014) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 29 Suppl 3. p.27-29(
- Contribution to journal › Published meeting abstract
-
Mark
Primary and secondary glomerulonephritides 1.
2014) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 29 Suppl 3(May). p.186-200(
- Contribution to journal › Article
-
Mark
Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease
(
- Contribution to journal › Article
- 2013
-
Mark
Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility
(
- Contribution to journal › Article
-
Mark
Excellent long time survival for Swedish patients starting home-hemodialysis with and without subsequent renal transplantations.
(
- Contribution to journal › Article
-
Mark
A Candidate Gene Approach to ANCA-Associated Vasculitis Reveals Links to the C3 and CTLA-4 Genes but not to the IL1-Ra And Fcγ-RIIa Genes.
(
- Contribution to journal › Article
- 2012
-
Mark
Different fractions of human serum glycoproteins bind galectin-1 or galectin-8, and their ratio may provide a refined biomarker for pathophysiological conditions in cancer and inflammatory disease.
(
- Contribution to journal › Article